Hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
impairs	O
natural	O
killer	I:C1317556
cell	I:C1317556
activity	I:C1317556
via	O
viral	O
serine	I:C2717971
protease	I:C2717971
NS3	I:C2717971
.	O

Hepatitis	O
C	I:C0220847
virus	I:C0220847
impairs	O
natural	B:C1317556
killer	I:C1317556
cell	I:C1317556
activity	I:C1317556
via	O
viral	O
serine	I:C2717971
protease	I:C2717971
NS3	I:C2717971
.	O

Hepatitis	O
C	I:C0220847
virus	I:C0220847
impairs	O
natural	O
killer	I:C1317556
cell	I:C1317556
activity	I:C1317556
via	O
viral	B:C2717971
serine	I:C2717971
protease	I:C2717971
NS3	I:C2717971
.	O

Hepatitis	B:C4288963
C	I:C4288963
virus	I:C4288963
(	I:C4288963
HCV	I:C4288963
)	I:C4288963
infection	I:C4288963
is	O
characterized	O
by	O
a	O
high	O
frequency	O
of	O
chronic	O
cases	O
owing	O
to	O
the	O
impairment	O
of	O
innate	O
and	O
adaptive	O
immune	I:C1155229
responses	I:C1155229
.	O

Hepatitis	O
C	I:C4288963
virus	I:C4288963
(	I:C4288963
HCV	I:C4288963
)	I:C4288963
infection	I:C4288963
is	O
characterized	O
by	O
a	O
high	O
frequency	O
of	O
chronic	O
cases	O
owing	O
to	O
the	O
impairment	O
of	O
innate	O
and	O
adaptive	B:C1155229
immune	I:C1155229
responses	I:C1155229
.	O

The	O
modulation	O
of	O
natural	B:C1317556
killer	I:C1317556
(	I:C1317556
NK	I:C1317556
)	I:C1317556
cell	I:C1317556
functions	I:C1317556
by	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
leads	O
to	O
an	O
impaired	O
innate	O
immune	O
response	O
.	O

The	O
modulation	O
of	O
natural	O
killer	I:C1317556
(	I:C1317556
NK	I:C1317556
)	I:C1317556
cell	I:C1317556
functions	I:C1317556
by	O
Hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
leads	O
to	O
an	O
impaired	O
innate	O
immune	O
response	O
.	O

However	O
,	O
the	O
underling	O
mechanisms	O
and	O
roles	O
of	O
HCV	B:C0042736
proteins	I:C0042736
in	O
this	O
immune	O
evasion	I:C1654934
are	O
controversial	O
,	O
especially	O
in	O
the	O
early	O
phase	O
of	O
HCV	O
infection	I:C4288963
.	O

However	O
,	O
the	O
underling	O
mechanisms	O
and	O
roles	O
of	O
HCV	O
proteins	I:C0042736
in	O
this	O
immune	B:C1654934
evasion	I:C1654934
are	O
controversial	O
,	O
especially	O
in	O
the	O
early	O
phase	O
of	O
HCV	O
infection	I:C4288963
.	O

However	O
,	O
the	O
underling	O
mechanisms	O
and	O
roles	O
of	O
HCV	O
proteins	I:C0042736
in	O
this	O
immune	O
evasion	I:C1654934
are	O
controversial	O
,	O
especially	O
in	O
the	O
early	O
phase	O
of	O
HCV	B:C4288963
infection	I:C4288963
.	O

To	O
investigate	O
the	O
role	O
of	O
HCV	B:C0069065
nonstructural	I:C0069065
proteins	I:C0069065
especially	O
NS3	O
in	O
the	O
impairment	O
of	O
NK	O
functions	I:C1317556
,	O
NK	O
cells	I:C0022688
were	O
isolated	O
from	O
the	O
PBMCs	O
by	O
negative	O
selection	I:C2347338
.	O

To	O
investigate	O
the	O
role	O
of	O
HCV	O
nonstructural	I:C0069065
proteins	I:C0069065
especially	O
NS3	B:C0249187
in	O
the	O
impairment	O
of	O
NK	O
functions	I:C1317556
,	O
NK	O
cells	I:C0022688
were	O
isolated	O
from	O
the	O
PBMCs	O
by	O
negative	O
selection	I:C2347338
.	O

To	O
investigate	O
the	O
role	O
of	O
HCV	O
nonstructural	I:C0069065
proteins	I:C0069065
especially	O
NS3	O
in	O
the	O
impairment	O
of	O
NK	B:C1317556
functions	I:C1317556
,	O
NK	O
cells	I:C0022688
were	O
isolated	O
from	O
the	O
PBMCs	O
by	O
negative	O
selection	I:C2347338
.	O

To	O
investigate	O
the	O
role	O
of	O
HCV	O
nonstructural	I:C0069065
proteins	I:C0069065
especially	O
NS3	O
in	O
the	O
impairment	O
of	O
NK	O
functions	I:C1317556
,	O
NK	B:C0022688
cells	I:C0022688
were	O
isolated	O
from	O
the	O
PBMCs	O
by	O
negative	O
selection	I:C2347338
.	O

To	O
investigate	O
the	O
role	O
of	O
HCV	O
nonstructural	I:C0069065
proteins	I:C0069065
especially	O
NS3	O
in	O
the	O
impairment	O
of	O
NK	O
functions	I:C1317556
,	O
NK	O
cells	I:C0022688
were	O
isolated	O
from	O
the	O
PBMCs	O
by	O
negative	B:C2347338
selection	I:C2347338
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	B:C0596402
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	B:C1819433
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	B:C0022688
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	B:C0282547
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	B:C0007634
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	B:C0012854
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	B:C0314641
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	B:C0007634
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	B:C0033684
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	B:C0035142
cells	O
.	O

To	O
assess	O
the	O
direct	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
,	O
co-cultured	O
with	O
uninfected	O
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
,	O
HCV	O
-	I:C0012854
NS3	I:C0012854
DNA	I:C0012854
-	O
transfected	O
Huh	O
-	I:C0007634
7.5	I:C0007634
,	O
or	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	B:C0007634
.	O

To	O
determine	O
the	O
effect	O
of	O
an	O
NS3	B:C0069065
serine	O
protease	I:C0036733
inhibitor	I:C0036733
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
were	O
treated	O
with	I:C0332293
BILN	O
-	I:C1313841
2061	I:C1313841
.	O

To	O
determine	O
the	O
effect	O
of	O
an	O
NS3	O
serine	B:C0036733
protease	I:C0036733
inhibitor	I:C0036733
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
were	O
treated	O
with	I:C0332293
BILN	O
-	I:C1313841
2061	I:C1313841
.	O

To	O
determine	O
the	O
effect	O
of	O
an	O
NS3	O
serine	O
protease	I:C0036733
inhibitor	I:C0036733
,	O
HCV	B:C0007634
-	I:C0007634
infected	I:C0007634
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
were	O
treated	O
with	I:C0332293
BILN	O
-	I:C1313841
2061	I:C1313841
.	O

To	O
determine	O
the	O
effect	O
of	O
an	O
NS3	O
serine	O
protease	I:C0036733
inhibitor	I:C0036733
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
Huh	B:C0007634
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
were	O
treated	O
with	I:C0332293
BILN	O
-	I:C1313841
2061	I:C1313841
.	O

To	O
determine	O
the	O
effect	O
of	O
an	O
NS3	O
serine	O
protease	I:C0036733
inhibitor	I:C0036733
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
were	O
treated	B:C0332293
with	I:C0332293
BILN	O
-	I:C1313841
2061	I:C1313841
.	O

To	O
determine	O
the	O
effect	O
of	O
an	O
NS3	O
serine	O
protease	I:C0036733
inhibitor	I:C0036733
,	O
HCV	O
-	I:C0007634
infected	I:C0007634
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
were	O
treated	O
with	I:C0332293
BILN	B:C1313841
-	I:C1313841
2061	I:C1313841
.	O

Then	O
,	O
NK	B:C0022688
cells	I:C0022688
were	O
harvested	O
and	O
further	O
co-cultured	O
with	O
K	O
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
.	O

Then	O
,	O
NK	O
cells	I:C0022688
were	O
harvested	B:C0022885
and	O
further	O
co-cultured	O
with	O
K	O
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
.	O

Then	O
,	O
NK	O
cells	I:C0022688
were	O
harvested	O
and	O
further	O
co-cultured	B:C0282547
with	O
K	O
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
.	O

Then	O
,	O
NK	O
cells	I:C0022688
were	O
harvested	O
and	O
further	O
co-cultured	O
with	O
K	B:C0600432
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
.	O

NK	B:C1317556
cell	I:C1317556
functions	I:C1317556
were	O
analyzed	O
by	O
flow	O
cytometry	I:C0016263
and	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
analyzed	B:C0936012
by	O
flow	O
cytometry	I:C0016263
and	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
analyzed	O
by	O
flow	B:C0016263
cytometry	I:C0016263
and	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
analyzed	O
by	O
flow	O
cytometry	I:C0016263
and	O
enzyme	B:C0014441
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
.	O

When	O
co-cultured	B:C0282547
with	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
,	O
the	O
natural	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
were	O
significantly	O
reduced	O
.	O

When	O
co-cultured	O
with	O
HCV	B:C4288963
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
,	O
the	O
natural	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
were	O
significantly	O
reduced	O
.	O

When	O
co-cultured	O
with	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	B:C0007634
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
,	O
the	O
natural	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
were	O
significantly	O
reduced	O
.	O

When	O
co-cultured	O
with	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
,	O
the	O
natural	O
cytotoxicity	B:C0596402
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
were	O
significantly	O
reduced	O
.	O

When	O
co-cultured	O
with	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
,	O
the	O
natural	O
cytotoxicity	O
and	O
IFN	B:C1819433
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	O
cells	I:C0022688
were	O
significantly	O
reduced	O
.	O

When	O
co-cultured	O
with	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
,	O
the	O
natural	O
cytotoxicity	O
and	O
IFN	O
-γ	I:C1819433
production	I:C1819433
capability	O
of	O
NK	B:C0022688
cells	I:C0022688
were	O
significantly	O
reduced	O
.	O

NK	B:C1317556
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	O
-	O
transfected	O
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	B:C0282547
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	O
-	O
transfected	O
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	B:C0033684
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	O
-	O
transfected	O
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	B:C0035142
cells	O
,	O
NS3	O
-	O
transfected	O
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	B:C0007634
,	O
NS3	O
-	O
transfected	O
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	B:C0069065
-	O
transfected	O
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	O
-	O
transfected	B:C0314641
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	O
-	O
transfected	O
cells	B:C0007634
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	O
-	O
transfected	O
cells	O
,	O
and	O
HCV	B:C4288963
-	I:C4288963
infected	I:C4288963
Huh	O
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

NK	O
cell	I:C1317556
functions	I:C1317556
were	O
inhibited	O
to	O
similar	O
levels	O
upon	O
co-culture	O
with	O
HCV	O
-	I:C0033684
NS	I:C0033684
replicon	O
cells	O
,	O
NS3	O
-	O
transfected	O
cells	O
,	O
and	O
HCV	O
-	I:C4288963
infected	I:C4288963
Huh	B:C0007634
-	I:C0007634
7.5	I:C0007634
cells	I:C0007634
.	O

These	O
reductions	O
were	O
restored	O
by	O
BILN	B:C1313841
-	I:C1313841
2061	I:C1313841
-	O
treatment	O
.	O

Furthermore	O
,	O
BILN	B:C1313841
-	I:C1313841
2061	I:C1313841
-	O
treatment	O
significantly	O
increased	O
degranulation	O
against	O
K	O
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
and	O
IFN	O
-γ	I:C1819433
productivity	I:C1819433
in	O
NK	O
cells	I:C0022688
.	O

Furthermore	O
,	O
BILN	O
-	I:C1313841
2061	I:C1313841
-	O
treatment	O
significantly	O
increased	O
degranulation	B:C0007588
against	O
K	O
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
and	O
IFN	O
-γ	I:C1819433
productivity	I:C1819433
in	O
NK	O
cells	I:C0022688
.	O

Furthermore	O
,	O
BILN	O
-	I:C1313841
2061	I:C1313841
-	O
treatment	O
significantly	O
increased	O
degranulation	O
against	O
K	B:C0600432
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
and	O
IFN	O
-γ	I:C1819433
productivity	I:C1819433
in	O
NK	O
cells	I:C0022688
.	O

Furthermore	O
,	O
BILN	O
-	I:C1313841
2061	I:C1313841
-	O
treatment	O
significantly	O
increased	O
degranulation	O
against	O
K	O
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
and	O
IFN	B:C1819433
-γ	I:C1819433
productivity	I:C1819433
in	O
NK	O
cells	I:C0022688
.	O

Furthermore	O
,	O
BILN	O
-	I:C1313841
2061	I:C1313841
-	O
treatment	O
significantly	O
increased	O
degranulation	O
against	O
K	O
-	I:C0600432
562	I:C0600432
target	I:C0600432
cells	I:C0600432
and	O
IFN	O
-γ	I:C1819433
productivity	I:C1819433
in	O
NK	B:C0022688
cells	I:C0022688
.	O

Consistent	O
with	O
these	O
findings	B:C0243095
,	O
the	O
expression	O
levels	O
of	O
activating	O
NK	O
cell	I:C2350463
receptors	I:C2350463
,	O
such	O
as	O
NKp46	O
and	O
NKp30	O
,	O
were	O
also	O
increased	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
the	O
expression	O
levels	O
of	O
activating	O
NK	B:C2350463
cell	I:C2350463
receptors	I:C2350463
,	O
such	O
as	O
NKp46	O
and	O
NKp30	O
,	O
were	O
also	O
increased	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
the	O
expression	O
levels	O
of	O
activating	O
NK	O
cell	I:C2350463
receptors	I:C2350463
,	O
such	O
as	O
NKp46	B:C2757033
and	O
NKp30	O
,	O
were	O
also	O
increased	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
the	O
expression	O
levels	O
of	O
activating	O
NK	O
cell	I:C2350463
receptors	I:C2350463
,	O
such	O
as	O
NKp46	O
and	O
NKp30	B:C2757035
,	O
were	O
also	O
increased	O
.	O

In	O
HCV	B:C4288963
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	O
of	O
NKp46	O
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	B:C0007634
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	O
of	O
NKp46	O
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	B:C2717971
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	O
of	O
NKp46	O
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	B:C1317556
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	O
of	O
NKp46	O
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	B:C3714514
through	O
downregulation	O
of	O
NKp46	O
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	B:C0013081
of	O
NKp46	O
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	O
of	O
NKp46	B:C2757033
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	O
of	O
NKp46	O
and	O
NKp30	B:C2757035
receptors	I:C2757035
on	O
NK	O
cells	I:C0022688
.	O

In	O
HCV	O
-	I:C4288963
infected	I:C4288963
cells	O
,	O
the	O
serine	O
protease	I:C2717971
NS3	I:C2717971
may	O
play	O
a	O
role	O
in	O
the	O
abrogation	O
of	O
NK	O
cell	I:C1317556
functions	I:C1317556
in	O
the	O
early	O
phase	O
of	O
infection	O
through	O
downregulation	O
of	O
NKp46	O
and	O
NKp30	O
receptors	I:C2757035
on	O
NK	B:C0022688
cells	I:C0022688
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
NS3	B:C0069065
represents	O
a	O
novel	O
drug	O
target	I:C0085104
for	O
the	O
treatment	O
of	O
HCV	O
infections	I:C4288963
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
NS3	O
represents	O
a	O
novel	O
drug	B:C0085104
target	I:C0085104
for	O
the	O
treatment	O
of	O
HCV	O
infections	I:C4288963
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
NS3	O
represents	O
a	O
novel	O
drug	O
target	I:C0085104
for	O
the	O
treatment	O
of	O
HCV	B:C4288963
infections	I:C4288963
.	O

